Literature DB >> 15196249

The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation.

H Kobayashi1, O Hosono, S Iwata, H Kawasaki, M Kuwana, H Tanaka, N H Dang, C Morimoto.   

Abstract

Human CD4+ T cells can be divided into reciprocal memory and naive T cell subsets based on their expression of CD45 isoforms and CD29/integrin beta1 subunit. To identify unique cell surface molecules on human T cells, we developed a new monoclonal antibody termed anti5H9. Binding of anti5H9 triggers a co-stimulatory response in human peripheral blood T cells. Retrovirus-mediated expression cloning has revealed that the antigen recognized by anti5H9 is identical to the tetraspanin CD9. We now show that human CD9 is preferentially expressed on the CD4(+)CD45RA+ naive T cell subset, and that CD9(+)CD45RA+ T cells respond preferentially to the recombinant beta2-glycoprotein I, compared to CD9-CD45RA+ T cells. Furthermore, anti5H9 inhibits both the recombinant beta2-glycoprotein I- and the recall antigen tetanus toxoid-specific T cell proliferation. These results suggest that the tetraspanin CD9 plays an important role in T cell activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196249      PMCID: PMC1809091          DOI: 10.1111/j.1365-2249.2004.02494.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

Review 1.  Autoreactivity, dynamic tuning and selectivity.

Authors:  Z Grossman; W E Paul
Journal:  Curr Opin Immunol       Date:  2001-12       Impact factor: 7.486

2.  Tissue-specific migration pathways by phenotypically distinct subpopulations of memory T cells.

Authors:  C R Mackay; W L Marston; L Dudler; O Spertini; T F Tedder; W R Hein
Journal:  Eur J Immunol       Date:  1992-04       Impact factor: 5.532

3.  Severely reduced female fertility in CD9-deficient mice.

Authors:  F Le Naour; E Rubinstein; C Jasmin; M Prenant; C Boucheix
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

4.  The gamete fusion process is defective in eggs of Cd9-deficient mice.

Authors:  K Kaji; S Oda; T Shikano; T Ohnuki; Y Uematsu; J Sakagami; N Tada; S Miyazaki; A Kudo
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

5.  T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals.

Authors:  N Hattori; M Kuwana; J Kaburaki; T Mimori; Y Ikeda; Y Kawakami
Journal:  Arthritis Rheum       Date:  2000-01

6.  The human autologous mixed lymphocyte reaction. III. Immune circuits.

Authors:  J S Smolen; T M Chused; E A Novotny; A D Steinberg
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

7.  Human autoreactive CD4+ T cells from naive CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specificity and functional antigen avidity.

Authors:  P A Muraro; M Pette; B Bielekova; H F McFarland; R Martin
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

8.  Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions.

Authors:  K P Knobeloch; M D Wright; A F Ochsenbein; O Liesenfeld; J Löhler; R M Zinkernagel; I Horak; Z Orinska
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

9.  Murine CD9 is the receptor for pregnancy-specific glycoprotein 17.

Authors:  Roseann Waterhouse; Cam Ha; Gabriela S Dveksler
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

10.  P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody.

Authors:  J H Kersey; T W LeBien; C S Abramson; R Newman; R Sutherland; M Greaves
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  14 in total

1.  Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81.

Authors:  Yael Sagi; Angela Landrigan; Ronald Levy; Shoshana Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Neutrophils activate alveolar macrophages by producing caspase-6-mediated cleavage of IL-1 receptor-associated kinase-M.

Authors:  Hiroshi Kobayashi; Anna Nolan; Bushra Naveed; Yoshihiko Hoshino; Leopoldo N Segal; Yoko Fujita; William N Rom; Michael D Weiden
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

3.  CD151 Expression Is Associated with a Hyperproliferative T Cell Phenotype.

Authors:  Lillian Seu; Christopher Tidwell; Laura Timares; Alexandra Duverger; Frederic H Wagner; Paul A Goepfert; Andrew O Westfall; Steffanie Sabbaj; Olaf Kutsch
Journal:  J Immunol       Date:  2017-09-27       Impact factor: 5.422

4.  Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer.

Authors:  Xuan Han; Wu-Hu Zhang; He-Li Gao; Tian-Jiao Li; Hua-Xiang Xu; Hao Li; Peng-Cheng Li; Xu Wang; Xian-Jun Yu; Wen-Quan Wang; Liang Liu
Journal:  J Clin Lab Anal       Date:  2022-05-27       Impact factor: 3.124

Review 5.  Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.

Authors:  S Detchokul; E D Williams; M W Parker; A G Frauman
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

6.  Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets.

Authors:  Ping Jin; Ena Wang; Maurizio Provenzano; Sara Deola; Silvia Selleri; Jiaqiang Ren; Sonia Voiculescu; David Stroncek; Monica C Panelli; Francesco M Marincola
Journal:  J Transl Med       Date:  2006-06-28       Impact factor: 5.531

7.  CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells.

Authors:  Lucas Touzet; Florent Dumezy; Christophe Roumier; Céline Berthon; Claire Bories; Bruno Quesnel; Claude Preudhomme; Thomas Boyer
Journal:  Cancer Med       Date:  2019-02-10       Impact factor: 4.452

8.  A novel myeloid cell in murine spleen defined through gene profiling.

Authors:  Ying-Ying Hey; Terence J O'Neill; Helen C O'Neill
Journal:  J Cell Mol Med       Date:  2019-06-18       Impact factor: 5.310

9.  CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells.

Authors:  Toshihiro Okamoto; Satoshi Iwata; Hiroto Yamazaki; Ryo Hatano; Eriko Komiya; Nam H Dang; Kei Ohnuma; Chikao Morimoto
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

Review 10.  CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?

Authors:  Carole Brosseau; Luc Colas; Antoine Magnan; Sophie Brouard
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.